ABSTRACT
Autohemotransfusion is one of the perspective methods of transfusion used in cardiosurgery. Intraoperative autohemotransfusion was used in surgical correction of congenital heart diseases in patients of various age groups, including children aged 6 to 8. The exfusion volume made up 300-600 ml, depending on the patient's body mass and the hematologic parameters. Clinical follow-up and assessment of the laboratory parameters have proved the possibility of blood exfusion in the patients with the blue congenital heart disease. Autoblood infusion was performed directly after artificial circulation switch-off, this providing a better hemostasis stabilization and correction of the patient's hemogram. Autoblood volume in blood substitution made up 30% on an average, this saving donor blood.
Subject(s)
Blood Transfusion, Autologous , Heart Defects, Congenital/surgery , Adolescent , Adult , Child , Follow-Up Studies , Humans , Intraoperative CareABSTRACT
Results of differentiated administration of blood components to cardiac surgical patients are presented. Frozen washed erythrocytes and erythromass were successively used in the perfusate and postoperatively. A transfusion pattern for patients with rare A2B blood group has been elaborated. The feasibility of prevention of artificial-circulation-induced thrombocytopenia by introduction of large quantities of platelet components right after AC is demonstrated. The necessity of the ACT-test for adequate blood heparinisation and neutralisation during the AC is established. Results of successful autohemotransfusion in cardiac surgery and application of fibrinolytic blood and its components are discussed.
